Shanghai Shyndec Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shanghai Hyundai Pharmaceutical Co., Ltd. (hereinafter referred to as "SDHY"), founded in 1996, is a high-tech enterprise in the pharmaceutical industry specializing in research, development, production and sales of pharmaceutical products, which was founded by academicians of the CAE Member. The company was listed on the Shanghai Stock Exchange on June 16, 2004 (code: 600420, abbreviated as Sinopharm Hyundai). In April 2010, he joined China Pharmaceutical Group Co., Ltd. (hereinafter referred to as "China National Pharmaceutical Group"). Sinopharm Modern comprehensively serves the national strategy of "Healthy China", with the development goal of achieving innovation driven, sustainable development, strengthening, optimizing, and becoming a big country with capital. The key task is to create a high-quality strategic pattern of "chemical pharmaceuticals as the main body, biopharmaceuticals and big health as the two wings", and uphold the corporate philosophy of Sinopharm Group of "protecting life and caring for health", Focusing on the five major treatment fields of "anti infection, cardiovascular and cerebrovascular disease, anti-tumor and immune regulation, metabolism and endocrine, and anesthesia", we coordinate and optimize the industrial layout, and achieve healthy and stable development through multi wheel drive. We are committed to becoming an innovation driven, China leading, and international first-class pharmaceutical enterprise, and becoming a dynamic, powerful, and influential industry leader. A specialized strategic development pattern has been formed with unified strategy, centralized resources, reasonable allocation, scale effect, and industrial chain linkage effect. |
| Headquarter | Shanghai |
| Establish Date | 11/27/1996 |
| Listed Code | 600420.SH |
| Listed Date | 6/16/2004 |
| Chairman | Dong Zenghe. |
| CEO | Lian Wanyong. |
| Website | www.shyndec.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
